echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Front Oncol: Systematic lymphadenectomy improves patient outcomes in patients with early-stage endometrial clear cell carcinoma

    Front Oncol: Systematic lymphadenectomy improves patient outcomes in patients with early-stage endometrial clear cell carcinoma

    • Last Update: 2022-04-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The survival value of systematic lymphadenectomy for endometrial cancer is unclear and controversial
    .


    Recently, a domestic team conducted a related study to evaluate the long-term survival effect of combined pelvic and para-aortic lymphadenectomy on patients with early-stage endometrial clear cell carcinoma


    The survival value of systematic lymphadenectomy for endometrial cancer is unclear and controversial


    The study included patients with early-stage endometrial clear cell carcinoma who underwent surgical staging from 2012 to 2017 in three Chinese teaching hospitals
    .


    The clinicopathological characteristics of patients with and without systematic lymphadenectomy were compared between the two groups


    The study included patients with early-stage endometrial clear cell carcinoma who underwent surgical staging from 2012 to 2017 in three Chinese teaching hospitals


    Systematic lymphadenectomy was performed in 244 patients and no lymph node dissection was performed in 89 patients


    The proportion of tumors of 2 cm and above in the two groups (48.
    0%, 52.
    9%, P=0.
    755), LVSI (24.
    2%, 21.
    3%, P>0.
    999), and positive peritoneal cytology (11.
    9% and 10.
    1%, P>0.
    999)
    .


    In terms of surgical staging, the rate of laparoscopic surgery in the systematic lymph node dissection group was 68.


    The proportion of tumors of 2 cm and above in the two groups (48.


    In patients who did not undergo systematic lymphadenectomy, the most common recurrence was lymph node recurrence (15.


    The 5-year disease-free survival rate of patients with systematic lymph node dissection was 64.
    10%, and the 5-year disease-free survival rate of patients without lymph node dissection was 45.
    05%
    .


    Patients who underwent systematic lymphadenectomy had better disease-free survival than those who did not (HR, 0.


    The 5-year disease-free survival rate of patients with systematic lymph node dissection was 64.


    The 5-year overall survival rate was 68.
    87% (95% CI, 62.
    33%-74.
    51%) in the lymphadenectomy group and 53.
    33% 53.
    33% (95% CI, 41.
    63) in patients without systematic lymphadenectomy %-63.
    69%)
    .


    Patients who underwent systematic lymphadenectomy had better overall survival than those who did not (HR, 0.


    The 5-year overall survival rate was 68.
    87% (95% CI, 62.
    33%-74.
    51%) in the lymphadenectomy group and 53.
    33% 53.
    33% (95% CI, 41.
    63) in patients without systematic lymphadenectomy %-63.
    69%)
    .
    Patients who underwent systematic lymphadenectomy had better overall survival than those who did not (HR, 0.
    58.
    95% CI, 0.
    39-0.
    85.
    P=0.
    005)
    .
    The 5-year overall survival rate was 68.
    87% (95% CI, 62.
    33%-74.
    51%) in the lymphadenectomy group and 53.
    33% 53.
    33% (95% CI, 41.
    63) in patients without systematic lymphadenectomy %-63.
    69%)
    .
    Patients who underwent systematic lymphadenectomy had better overall survival than those who did not (HR, 0.
    58.
    95% CI, 0.
    39-0.
    85.
    P=0.
    005)
    .

    Among patients undergoing systematic lymphadenectomy, survival analysis was performed by subclassification of the number of lymph nodes removed
    .
    Patients who had 10 to 20 or more regional lymph nodes removed had better DFS and OS than those who had less than 10 regional lymph nodes removed
    .

    Among patients undergoing systematic lymphadenectomy, survival analysis was performed by subclassification of the number of lymph nodes removed
    .
    Patients who had 10 to 20 or more regional lymph nodes removed had better DFS and OS than those who had less than 10 regional lymph nodes removed
    .
    Among patients undergoing systematic lymphadenectomy, survival analysis was performed by subclassification of the number of lymph nodes removed
    .
    Patients who had 10 to 20 or more regional lymph nodes removed had better DFS and OS than those who had less than 10 regional lymph nodes removed
    .

    After adjusting for relevant variables, systematic lymphadenectomy was still associated with improved DFS (aHR, 0.
    57, 95%CI 0.
    39-0.
    85, P=0.
    005) and OS (aHR, 0.
    64, 95) in patients with early stage endometrial clear cell carcinoma %CI, 0.
    41-0.
    99, P=0.
    047) were independently correlated
    .

    After adjusting for relevant variables, systematic lymphadenectomy was still associated with improved DFS (aHR, 0.
    57, 95%CI 0.
    39-0.
    85, P=0.
    005) and OS (aHR, 0.
    64, 95) in patients with early stage endometrial clear cell carcinoma %CI, 0.
    41-0.
    99, P=0.
    047) were independently correlated
    .
    After adjusting for relevant variables, systematic lymphadenectomy was still associated with improved DFS (aHR, 0.
    57, 95%CI 0.
    39-0.
    85, P=0.
    005) and OS (aHR, 0.
    64, 95) in patients with early stage endometrial clear cell carcinoma %CI, 0.
    41-0.
    99, P=0.
    047) were independently correlated
    .

    In conclusion, the study showed that patients with early-stage endometrial clear cell carcinoma who underwent systematic lymphadenectomy had better long-term survival than those who did not
    .

    In conclusion, the study showed that patients with early-stage endometrial clear cell carcinoma who underwent systematic lymphadenectomy had better long-term survival than those who did not
    .
    Studies have shown that patients with early-stage endometrial clear cell carcinoma who underwent systematic lymphadenectomy had better long-term survival than those who did not
    .
    Studies have shown that patients with early-stage endometrial clear cell carcinoma who underwent systematic lymphadenectomy had better long-term survival than those who did not
    .

     

    Original source:

    Original source:

    Tian Y, Ran L, Liu Y, Xu Y, Shen J, Mi Gs and Ke Fm (2022) Systematic Lymphadenectomy and Oncological Outcomes of Women With Apparent Early-Stage Clear Cell Carcinoma of the Endometrium: A Multi-Institutional Cohort Study.
    Front .
    Oncol.
    12:800957.
    doi: 10.
    3389/fonc.
    2022.
    800957.

    Tian Y, Ran L, Liu Y, Xu Y, Shen J, Mi Gs and Ke Fm (2022) Systematic Lymphadenectomy and Oncological Outcomes of Women With Apparent Early-Stage Clear Cell Carcinoma of the Endometrium: A Multi-Institutional Cohort Study.
    Front .
    Oncol.
    12:800957.
    doi: 10.
    3389/fonc.
    2022.
    800957.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.